We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£490.00
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis for US Zip Codes
Price data last checked 117 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£490 today · cheaper than every other day in the last 16 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 351 days • 351 data points (No recent data available)
Price Distribution
Price distribution over 351 days • 1 price levels
Price Analysis
Most common price: £490 (351 days, 100.0%)
Price range: £490 - £490
Price levels: 1 different prices over 351 days
Product Specifications
- Format
- paperback
- ASIN
- B0BSJHLRB2
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 09 January 2023
- Listed Since
- 26 January 2023
Similar Products You Might Like
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in Japan
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in the United States
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India
The 2025-2030 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis
The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States
The 2016 Report on Multiple Sclerosis Therapeutics: World Market Segmentation by City
The 2023 Report on Multiple Sclerosis Treatments: World Market Segmentation by City
The 2023-2028 Outlook for Advanced Therapy Medicinal Products for US Zip Codes
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs for US Zip Codes
The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa
The 2023-2028 Outlook for Bone Metabolism Therapeutics for US Zip Codes
The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan
The 2023-2028 Outlook for Business-to-Business Media Events for US Zip Codes
The 2016-2021 Outlook for Biosimilars in Asia & the Middle East
The 2023-2028 Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs for US Zip Codes
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in Japan
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments
IntechOpen
The 2023-2028 Outlook for Personal Therapy Products for US Zip Codes
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
The 2023-2028 Outlook for Metastatic Bone Diseases for US Zip Codes
Multiple Sclerosis in Children and Adolescents - Medical Book
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States
